NCT00886392|Completed
Diabetic Macular Edema Severity at Diagnosis
Distribution of Macular Edema Severity Level at the Moment of Diagnosis
Loading search results
Distribution of Macular Edema Severity Level at the Moment of Diagnosis
Sponsor study identifier
observational
118
1 country
1
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2007
Actual (reported)Study Completion
April 2008
Actual (reported)The purpose of this study is to identify the severity level distribution at the moment of diagnosis, in diabetic patients with macular edema from a Mexico City sample, and to identify the rate with severe macular edema that needed immediate treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
December 2007
Actual (reported)April 2008
Actual (reported)April 21, 2009
Actual (reported)April 22, 2009
Actual (reported)Thickening measured by optical coherence tomography in 3 zones: central subfield (when field 1 was thickened), inner ring (when any of fields 2, 3, 4 or 5 was thickened), and inner ring or outer ring (when any of fields 6, 7, 8, or 9 was thickened)
at the diagnosis moment
Severity level: adaptation of International clinical diabetic macular edema severity scale to fields of the OCT; mild if thickening exclusively involved outer-ring, moderate if was in inner-ring without involvement field 1, and severe if was in field 1
at the diagnosis moment
Type 2 diabetes patients who had clinically significant macular edema by the criterion of the ETDRS
Target population were type 2 diabetic patients with CSME who attended general hospitals of Mexico City and its metropolitan area; available population were patients with CSME evaluated at a general hospital
Hospital Juarez de Mexico
Mexico City, Mexico City, 07760, Mexico
Patricia Muñoz Ibarra, MD
Hospital Juarez de Mexico
Dulce M Razo Blanco Hernandez, MD
Hospital Juarez de Mexico
Virgilio Lima Gomez, MD, MsC
Hospital Juarez de Mexico
118 participants (actual enrollment reported by the registry).
First Submitted
April 21, 2009
First Posted
April 22, 2009
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
Contact the study team to confirm eligibility.
Primary Completion
December 2007
Actual (reported)Study Completion
April 2008
Actual (reported)Last Updated
April 22, 2009
Record last verified: 2009-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: